PainReform Ltd. (PRFX): Price and Financial Metrics


PainReform Ltd. (PRFX): $0.90

-0.05 (-5.02%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PRFX Stock Price Chart Interactive Chart >

Price chart for PRFX

PRFX Price/Volume Stats

Current price $0.90 52-week high $7.84
Prev. close $0.95 52-week low $0.71
Day low $0.89 Volume 10,900
Day high $0.95 Avg. volume 84,231
50-day MA $0.94 Dividend yield N/A
200-day MA $1.50 Market Cap 9.43M

PainReform Ltd. (PRFX) Company Bio


PainReform Ltd. operates as a pharmaceutical company. It develops and markets pharmaceuticals. The firm focuses on developing reformulation of pain therapeutics, PainReform applies its propriety formulation technologies to prolong and enhance efficacy, reduce adverse effects shortening recovery time and reduce the need of augmentation with drugs such as opioids and NSAIDS. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.


PRFX Latest News Stream


Event/Time News Detail
Loading, please wait...

PRFX Latest Social Stream


Loading social stream, please wait...

View Full PRFX Social Stream

Latest PRFX News From Around the Web

Below are the latest news stories about Painreform Ltd that investors may wish to consider to help them evaluate PRFX as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Grab a cup of coffee and get ready for another busy day of trading as we start with the biggest pre-market stock movers for Tuesday!

William White on InvestorPlace | January 11, 2022

PainReform CEO to Participate in the Benzinga All Access Event on December 16th

TEL AVIV, Israel, Dec. 14, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that Ilan Hadar, Chief Executive Officer of PainReform, will be participating in the Benzinga All Access event taking place on December 16, 2021. Mr. Hadar is scheduled to appear on December 16, 2021 at 10:00 A.M. Eastern Time. The event will consist of an int

Yahoo | December 14, 2021

AUPH Stock: 13 Things to Know About Aurinia Pharma as Shares Crash Today

Aurinia Pharma (AUPH) stock is taking a beating on Monday following a filing with the SEC after markets closed on Friday.

William White on InvestorPlace | November 22, 2021

PRFX Stock: 8 Things to Know About PainReform as Shares Trend on Unusually Heavy Volume Today

PainReform (PRFX) stock is on the move Monday with heavy trading despite a lack of news coming from the medical device company.

William White on InvestorPlace | November 22, 2021

Rivian News: 12 Things for RIVN Stock Investors to Know About a Potential Deal With RV Rental Company Outdoorsy

Rivian (RIVN) stock is in the news today thanks to talk from Outdoorsy about a potential deal for electric vehicles (EVs).

William White on InvestorPlace | November 22, 2021

Read More 'PRFX' Stories Here

PRFX Price Returns

1-mo -11.76%
3-mo -23.08%
6-mo -32.33%
1-year -67.15%
3-year N/A
5-year N/A
YTD -32.33%
2021 -70.25%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4972 seconds.